Cardiosense, Inc. — SEC Form D Filing
Cardiosense, Inc. filed an SEC Form D on August 24, 2026, reporting $26.14M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 24, 2026
- Amount reported
- $26.14M
- Round stage
- Series B, inferred from the $26.1 million raised through the conversion of promissory notes to equity to scale clinical validation and commercialization.
- Industry
- Other Health Care
- Website
- https://www.cardiosense.com
What the company does
Securities: Equity, Convertible Promissory Notes have converted into equity in connection with this transaction. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Heart failure patients lack continuous, noninvasive, and accurate hemodynamic monitoring at home, leading to preventable hospitalizations and delayed clinical interventions.
Solution
Cardiosense builds AI-powered, noninvasive wearable sensing hardware and software that provides continuous hemodynamic assessment for patients with heart failure.
Why now
Recent advancements in AI-driven physiological algorithms and the growing clinical adoption of remote patient monitoring technologies enable continuous, medical-grade cardiac assessment outside of traditional hospital settings.
Source: SEC EDGAR Form D filing